| CLSDX | VMGMX | CLSDX / VMGMX | |
| Total Expense Ratio | 0.87 | 0.07 | 1,243% |
| Annual Report Gross Expense Ratio | 0.88 | 0.07 | 1,257% |
| Fund Existence | 2 years | 15 years | - |
| Gain YTD | 18.648 | 9.762 | 191% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.3B | 33.5B | 7% |
| Annual Yield % from dividends | 0.00 | 0.61 | - |
| Returns for 1 year | 6.61 | 7.68 | 86% |
| Returns for 3 years | N/A | 51.17 | - |
| Returns for 5 years | N/A | 27.13 | - |
| Returns for 10 years | N/A | 190.62 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| KIQQ | 25.13 | 0.19 | +0.75% |
| KraneSharesInspereXNasdaqDynBfrdHInIdETF | |||
| PJP | 125.45 | 0.60 | +0.48% |
| Invesco Pharmaceuticals ETF | |||
| CPRY | 28.16 | -0.01 | -0.05% |
| Calamos Russell 2000 Str Alt Prt ETF-Jan | |||
| IBDV | 21.58 | -0.06 | -0.25% |
| iShares iBonds Dec 2030 Term Corp ETF | |||
| IZRL | 29.77 | -0.19 | -0.63% |
| ARK Israel Innovative Technology ETF | |||